Drugs / TOMM34
last change Mar 2009 re-read 2 minutes ago

TOMM34

Peptide

Developed for
colon carcinoma · rectal cancer
Investigated by
Human Genome Center, Institute of Medical Science, University of Tokyo · Tokyo University

Trials 1 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00677287 May 2008 → Mar 2009 colon carcinoma, rectal cancer Tokyo University Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TOMM34 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00677287
Modality Peptide “TOMM34 peptide (1mg)” NCT00677287